產品詳情
簡單介紹：
Anti-NCOA62抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-NCOA62抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-NCOA62
Cat. Number:
Anti-NCOA62抗體KL-19053R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene, a member of the SNW gene family, encodes a coactivator that enhances transcription from some Pol II promoters. This coactivator can bind to the ligand-binding domain of the vitamin D receptor and to retinoid receptors to enhance vitamin D-, retinoic acid-, estrogen-, and glucocorticoid-mediated geneAnti-NCOA62抗體 expression. It can also function as a splicing factor by interacting with poly(A)-binding protein 2 to directly control the expression of muscle-specific genes at the transcriptional level. Finally, the protein may be involved in oncogenesis since it interacts with a region of SKI oncoproteins that is required for transforming activity. [provided by RefSeq, Jul 2008]
Also known as:
Bx 42; Bx42; Homolog of Drosophila BX42; Anti-NCOA62抗體MGC119379; NCOA 62; Nuclear protein SkiP; Nuclear receptor coactivator 62 kD; Nuclear receptor coactivator NCoA 62; Nuclear receptor coactivator NCoA62; Prp 45; Prp45; PRPF 45; PRPF45; Ski interacting protein; SKIIP; SKIP; SNW 1; SNW1_HUMAN; SNW domain containing 1; SNW domain containing protein 1; SNW1; SNW1 protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Cow, Horse, Sheep, .
●
Immunogen: KLH conjugated syntheticAnti-NCOA62抗體 peptide derived from human NCOA62.
●
Predicted Molecular Weight: 61kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-NCOA62抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-NCOA62抗體
Optimal working dilutions must be determined by the end user.
